Dr. Reddy's Labs Files 6-K, Confirms 20-F Reporting
Ticker: RDY · Form: 6-K · Filed: Aug 30, 2024 · CIK: 1135951
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
DRL files 6-K, confirms 20-F for annual reports. Standard procedure.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on August 30, 2024, reporting as a foreign private issuer. The filing indicates the company is submitting its annual reports under cover of Form 20-F. The company's principal executive office is located in Hyderabad, Telangana, India.
Why It Matters
This filing confirms Dr. Reddy's Laboratories' adherence to SEC reporting requirements for foreign private issuers, providing transparency for investors.
Risk Assessment
Risk Level: low — This is a routine filing confirming reporting status and is not indicative of new risks.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001135951 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification
- 001-15182 (company) — SEC File Number
- 241268500 (company) — Film Number
- August, 2024 (date) — Report Date
- 20240830 (date) — Filing Date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report as a foreign private issuer and to confirm that the registrant files its annual reports under cover of Form 20-F.
What is the company's name and location?
The company's name is DR. REDDY'S LABORATORIES LIMITED, and its principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the SEC file number for Dr. Reddy's Laboratories?
The SEC file number for Dr. Reddy's Laboratories is 001-15182.
What is the Standard Industrial Classification code for the company?
The Standard Industrial Classification code for the company is 2834, which corresponds to Pharmaceutical Preparations.
Does the filing indicate any specific financial transactions or material events?
This specific filing (Form 6-K) does not detail specific financial transactions or material events; it primarily serves to report the company's status as a foreign private issuer and its reporting practices.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-08-30 13:11:14
Filing Documents
- drr0664_6k.htm (6-K) — 13KB
- drr0664_ex99-1.htm (EX-99.1) — 7KB
- drr0664_ex99-1img01.jpg (GRAPHIC) — 9KB
- drr0664_ex99-1img02.jpg (GRAPHIC) — 9KB
- 0001575872-24-000961.txt ( ) — 47KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: August 30, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3